Jennifer Effie Amengual

8PUBLICATIONS
47CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursPredictive and prognostic markersPerforming arts not elsewhere classifiedTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 09, 2026
A randomized phase 2 study of ipilimumab, nivolumab, and brentuximab vedotin in patients with relapsed Hodgkin lymphoma.

Catherine Diefenbach, Opeyemi Jegede, Victoria Wang

|Oct 24, 2023
Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma.

James N Gerson, Elizabeth Handorf, Diego Villa

|Jul 17, 2023
Context-defined cancer co-dependency mapping identifies a functional interplay between PRC2 and MLL-MEN1 complex in lymphoma.

Xiao Chen, Yinglu Li, Fang Zhu

|Apr 27, 2023
Queen's gambit: response-adapted win in CAYA with cHL.

Seda S Tolu, Jennifer E Amengual

|Nov 03, 2022
A Tet-a-Tet in T follicular helper cell lymphoma.

Jennifer E Amengual

|Aug 26, 2022
Targeting CD38 with Daratumumab Plus Chemotherapy for Patients with Advanced-Stage Plasmablastoid Large B-Cell Lymphoma.

Yun Kyoung Ryu, Edd C Ricker, Craig R Soderquist

Pageof 2

Frequent Collaborators

2 joint publications

David W Scott

2 joint publications

Jonathon B Cohen

2 joint publications

Lale Kostakoglu

1 joint publications

Grzegorz S Nowakowski